263 related articles for article (PubMed ID: 15219506)
1. Assessment of systemic inflammation and infective pathogen burden in patients with cardiac syndrome X.
Lanza GA; Sestito A; Cammarota G; Grillo RL; Vecile E; Cianci R; Speziale D; Dobrina A; Maseri A; Crea F
Am J Cardiol; 2004 Jul; 94(1):40-4. PubMed ID: 15219506
[TBL] [Abstract][Full Text] [Related]
2. Role of Chlamydia pneumoniae, helicobacter pylori and cytomegalovirus in coronary artery disease.
Al-Ghamdi A; Jiman-Fatani AA; El-Banna H
Pak J Pharm Sci; 2011 Apr; 24(2):95-101. PubMed ID: 21454155
[TBL] [Abstract][Full Text] [Related]
3. [Prevalence of intimal pathogen burden in acute coronary syndromes].
Andrié R; Braun P; Heinrich KW; Lüderitz B; Bauriedel G
Z Kardiol; 2003 Aug; 92(8):641-9. PubMed ID: 12955411
[TBL] [Abstract][Full Text] [Related]
4. [Study on the correlation of between infection, inflammation and coronary artery disease].
Cai XJ; Cai HB; Lu D
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jun; 24(6):503-7. PubMed ID: 12848920
[TBL] [Abstract][Full Text] [Related]
5. Serological markers of Chlamydia pneumoniae, cytomegalovirus and Helicobacter pylori infection in diabetic and non-diabetic patients with unstable angina pectoris.
Altannavch Ts; Roubalová K; Broz J; Hrubá D; Andĕl M
Cent Eur J Public Health; 2003 Jun; 11(2):102-6. PubMed ID: 12884557
[TBL] [Abstract][Full Text] [Related]
6. [Infections with Chlamydia pneumoniae, Helicobacter pylori or cytomegalovirus and atherosclerosis].
Grabczewska Z; Nartowicz E
Przegl Lek; 1999; 56(9):584-7. PubMed ID: 10695364
[TBL] [Abstract][Full Text] [Related]
7. Absence of association between infectious agents and endothelial function in healthy young men.
Khairy P; Rinfret S; Tardif JC; Marchand R; Shapiro S; Brophy J; Dupuis J
Circulation; 2003 Apr; 107(15):1966-71. PubMed ID: 12681997
[TBL] [Abstract][Full Text] [Related]
8. C-Reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes.
Abdelmouttaleb I; Danchin N; Ilardo C; Aimone-Gastin I; Angioï M; Lozniewski A; Loubinoux J; Le Faou A; Guéant JL
Am Heart J; 1999 Feb; 137(2):346-51. PubMed ID: 9924170
[TBL] [Abstract][Full Text] [Related]
9. Detection of Helicobacter pylori and Chlamydia pneumoniae DNA in human coronary arteries and evaluation of the results with serologic evidence of inflammation.
Adiloglu AK; Ocal A; Can R; Duver H; Yavuz T; Aridogan BC
Saudi Med J; 2005 Jul; 26(7):1068-74. PubMed ID: 16047055
[TBL] [Abstract][Full Text] [Related]
10. Level of high-sensitivity C-reactive protein in Saudi patients with chronic stable coronary artery disease.
Habib SS
J Ayub Med Coll Abbottabad; 2008; 20(2):3-6. PubMed ID: 19385446
[TBL] [Abstract][Full Text] [Related]
11. Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes.
Miller GE; Freedland KE; Duntley S; Carney RM
Am J Cardiol; 2005 Feb; 95(3):317-21. PubMed ID: 15670537
[TBL] [Abstract][Full Text] [Related]
12. Incidence of Chlamydia pneumoniae infection in patients with coronary artery disease subjected to angioplasty or bypass surgery.
Pieniazek P; Karczewska E; Stepień E; Tracz W; Konturek SJ
Med Sci Monit; 2001; 7(5):995-1001. PubMed ID: 11535948
[TBL] [Abstract][Full Text] [Related]
13. Serum and peripheral blood mononuclear cells infectious burden: correlation to inflammation and atherosclerosis in haemodialysis patients.
Tsirpanlis G; Chatzipanagiotou S; Ioannidis A; Boufidou F; Moutafis S; Nicolaou C
Nephrology (Carlton); 2005 Jun; 10(3):256-63. PubMed ID: 15958038
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of infection and inflammation markers for late cardiac events in an Iranian sample.
Sarrafzadegan N; Rezaporian P; Kaypour M; Mohseni M; Sadeghi M; Asgary S; Sabet B
East Mediterr Health J; 2008; 14(6):1246-56. PubMed ID: 19161100
[TBL] [Abstract][Full Text] [Related]
15. Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris.
Saleh N; Svane B; Jensen J; Hansson LO; Nordin M; Tornvall P
Am Heart J; 2005 May; 149(5):876-82. PubMed ID: 15894971
[TBL] [Abstract][Full Text] [Related]
16. Platelet reactivity in response to mental stress in syndrome X and in stable or unstable coronary artery disease.
Sestito A; Maccallini A; Sgueglia GA; Infusino F; Larosa C; Aurigemma C; Crea F; Lanza GA
Thromb Res; 2005; 116(1):25-31. PubMed ID: 15850605
[TBL] [Abstract][Full Text] [Related]
17. Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease.
Wu TC; Leu HB; Lin WT; Lin CP; Lin SJ; Chen JW
Eur J Clin Invest; 2005 Sep; 35(9):537-45. PubMed ID: 16128859
[TBL] [Abstract][Full Text] [Related]
18. Seropositivity to Chlamydia pneumoniae or Helicobacter pylori and coronary artery disease.
Sotiropoulos A; Gikas A; Skourtis S; Merkouris P; Pentzeridis P; Polydorou A; Pappas S
Int J Cardiol; 2006 May; 109(3):420-1. PubMed ID: 15993502
[TBL] [Abstract][Full Text] [Related]
19. The role of infection in atherosclerosis and coronary artery disease: a new therapeutic target.
Ismail A; Khosravi H; Olson H
Heart Dis; 1999; 1(4):233-40. PubMed ID: 11720630
[TBL] [Abstract][Full Text] [Related]
20. In vitro hyperreactivity to lipopolysaccharide in patients with history of unstable angina is not associated with seropositivity for Cytomegalovirus, Helicobacter pylori and Chlamydia pneumoniae.
Colizzi C; Rizzello V; Angiolillo DJ; Liuzzo G; Ginnetti F; Monaco C; Comerci G; Vitrella G; Maseri A; Biasucci LM
Cardiologia; 1999 Apr; 44(4):377-80. PubMed ID: 10371790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
